Arab News, Thursday, Oct 21, 2021 | Rabi Al-Awwal 14, 1443
Saudi firm Tabuk Pharmaceutical strikes deal to manufacture Leosons products in the MENA
Saudi Arabia: Saudi-based Tabuk
Pharmaceutical Manufacturing Company has announced an exclusive agreement with
Leosons Overseas Corporation to manufacture and sell Leosons products in the
MENA region,
The agreement gives Tabuk Pharmaceutical an
immediate take over of the US-based company's existing business in more than 10
markets, with future expansion plans to include new regions and products.
Tabuk Pharmaceutical will have the right to
register, manufacture, and commercialize a range of 14 brands in several
countries in the MENA region, according to the agreement.
"We consider this partnership a step forward
towards augmenting our plans for long-term growth and strengthening Tabuk’s over
the counter business with direct contact with patients,” Wisam Alkhatib, vice
president of Strategy and Business Development at Tabuk Pharmaceuticals said.
“We believe our partnership with Tabuk
Pharmaceuticals is transformational especially in Saudi Arabia,” John L.
Ohanian, President of Leosons said.